Sham Innovation Santé
VC Fund
Lyon, France
Sham Innovation Santé is a VC fund in Lyon focused on Biotechnology and Medical Device. Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Sham Innovation Santé invests in
Stages Sham Innovation Santé invests in
Countries Sham Innovation Santé invests in
Round sizes
Round size
- Series A
- $6.1M–$74M
- Series B
- $10M–$80M
- Venture - Series Unknown
- $1.8M–$12M
Investment Focus
Industry
- Biotechnology 6 (38%)
- Medical Device 5 (31%)
- Medical 4 (25%)
- Health Care 4 (25%)
- Pharmaceutical 3 (19%)
Stage
- Series B 5 (31%)
- Series A 3 (19%)
- Venture - Series Unknown 3 (19%)
- Seed 2 (13%)
- Funding Round 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Therapixel
|
Therapixel develops and commercializes AI-based software for breast cancer detection and characterization | $15.6M / Series B / May 12, 2022 | |
Germitec SAS
|
Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system. | $11.6M / Venture - Series Unknown / May 10, 2022 | |
Cairdac
|
Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation. | $18.8M / Series A / Mar 31, 2022 | |
Amolyt Pharma
|
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism. | $80M / Series B / Sep 16, 2021 | |
Keenturtle
|
Keenturtle is a medtech that provides e-health solutions to enhance medical & economic field such as provision of health data. | $1.8M / Venture - Series Unknown / Aug 02, 2021 | |
Coave Therapeutics
|
Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases. | $38.9M / Series B / Jul 21, 2021 | |
Mablink Bioscience
|
Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC). | $4.8M / Seed / Apr 27, 2021 | |
AbolerIS Pharma
|
AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance. | $2.9M / Seed / Nov 04, 2020 | |
|
Amolyt Pharma
|
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism. | $74.2M / Series A / Jul 31, 2019 | |
CarThera
|
CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since.The company’s proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reachthe brain. | $10.2M / Series B / Dec 12, 2018 | |
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sham Innovation Santé invest in?
Sham Innovation Santé invests primarily in Biotechnology, Medical Device and Medical startups, most often at Series B and Series A stage. Most of the 16 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sham Innovation Santé's check size?
Sham Innovation Santé typically joins rounds of $6.1M–$74M at Series A, $10M–$80M at Series B and $1.8M–$12M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sham Innovation Santé participates in.
When did Sham Innovation Santé last invest?
The most recent investment recorded for Sham Innovation Santé closed in May 2022. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
